Feb 09, 2024 / 09:00AM GMT
Presentation
Feb 09, 2024 / 09:00AM GMT
=====================
Corporate Participants
=====================
* Magnus Corfitzen
Ascelia Pharma AB - CEO
* Andreas Norlin
Ascelia Pharma AB - Chief Scientific Officer
* Julie Waras Brogren
Ascelia Pharma AB - Deputy CEO & Chief Commercial Officer
=====================
Conference Call Participants
=====================
* Ludvig Svensson
Carnegie Investment Bank - Analyst
* Johan Unnerus
Redeye AB - Analyst
=====================
Operator
This call is being recorded. Welcome to Ascelia Pharma Q4 2023 report presentation. (Operator Instructions)
Now, I will hand the conference over to CEO, Magnus Corfitzen; CSO, Andreas Norlin; Deputy CEO, Finance, Investor Relations, and Commercial, Julie Waras Brogren. Please go ahead.
Magnus Corfitzen - Ascelia Pharma AB - CEO
Thank you, and welcome, everyone, to the webcast for Ascelia Pharma's Q4 report and full-year report for 2023. The
Q4 2023 Ascelia Pharma AB Earnings Presentation Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
